MATES, Sharon,FIENBERG, Allen A.,WENNOGLE, Lawrence P.
申请号：
HK16107323.5
公开号：
HK1219306A
申请日:
2016.06.23
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
Use of particular substituted heterocycle fused gamma-carboline compounds as pharmaceuticals and pharmaceutical compositions comprising them for the treatment of one or more disorders involving the 5-HT 2A , SERT and/or dopamine D 2 pathways are disclosed. In addition, the compounds may be combined with other therapeutic agents for the treatment of one or more sleep disorders, depression, psychosis, dyskinesias, and/or Parkinsons disease or any combinations.
